GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Black Bird Biotech Inc (OTCPK:BBBT) » Definitions » Net Issuance of Preferred Stock

Black Bird Biotech (Black Bird Biotech) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Black Bird Biotech Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Black Bird Biotech's net issuance of preferred for the three months ended in Sep. 2023 was $0.00 Mil. The number is 0, which means that Black Bird Biotech has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Black Bird Biotech's net issuance of preferred for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.


Black Bird Biotech Net Issuance of Preferred Stock Historical Data

The historical data trend for Black Bird Biotech's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Black Bird Biotech Net Issuance of Preferred Stock Chart

Black Bird Biotech Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Issuance of Preferred Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Black Bird Biotech Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Black Bird Biotech Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Black Bird Biotech Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Black Bird Biotech's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Black Bird Biotech (Black Bird Biotech) Business Description

Traded in Other Exchanges
N/A
Address
11961 Hilltop Road, Suite 22, Argyle, TX, USA, 76226
Black Bird Biotech Inc is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. In addition, it is the distributor in the U. S. and Canada for MiteXstream, an EPA-registered plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee, and house plants, as well as molds and mildew. Its products include MiteXstream Biopesticide, Grizzly Creek Naturals, and Black Bird American Hemp.
Executives
Jeffrey A Collins director, 10 percent owner, officer: President 302 WASHINGTON ST., #513, SAN DIEGO CA 92103
Robert Edward Shea director, 10 percent owner, officer: President, CEO, CFO, CAO 40 WARREN STREET, 3RD FLOOR, CHARLESTOWN MA 02129
John James Sutherland director, 10 percent owner, officer: President, CEO, CFO & CAO C/O SUITE 810 - 675 WEST HASTINGS STREET, VANCOUVER A1 V6B 1N2